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Five years clinical results after matrix assisted autologous 
chondrocyte transplantation using a hyaluronan matrix
S. Nehrer1, S. Domayer2, R. Dorotka3;
1Center For Rgenerative Medicine, Danube University Krems, Krems, 
Austria, 2Orthopaedic Surgery, Medical University of Vienna, Vienna, 
Austria, 3Orthopedic Department, University of Vienna, Vienna, 
Austria
Purpose: Various biomaterials have been used in matrix assisted 
chondrocyte transplantation to improve articular cartilage repair. 
Hyaluronan was introduced successfully to transplant cultured 
DIPOESPDZUFTJODBSUJMBHFEFGFDUT5IJTTUVEZQSFTFOUTUIF¾STU¾WF
years clinical result using the Hyalograft technique. 
Methods and Materials: Between December 2000 and November 
2005 51 patients were treated with Hyalograft C in the knee joint. 29 
were male, 22 female, 48 had single defects, 3 had multiple defects. 
Mean defect size was 4.4 cm2. 39 cases showed defects on the 
medial femoral condyle (MFC), 6 cases on the lateral femoral condyle 
(LFC). 2 had patellar defects, 1 tibial, 1 MFC/LFC, 1 tibial/MFC and in 
one case multiple defects on the MFC were treated. Clinical follow up 
was performed at 1,3 and 5 years with three knee scoring systems: 
UIF-ZTIPMN4DPSFBNPEJ¾FE$JODJOOBUJ,OFF4DPSFBOEUIF*,%$
Score. 
Results: At 5-years follow-up the preoperative Lysholm Score 
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Overall in 44 patients the clincical outcome at 1 and 3 years 
JNQSPWFETJHOJ¾DBOUMZIPXFWFSGBJMVSFTXFSFHSBGUEFMBNJOBUJPO
and 8 patients with total knee replacement due to progressing 
osteoarthritis. 
Conclusions: Hyalograft is a useful treatment option for cartilage 
defects with outcome comparable to autologous chondrocyte 
implantation. Simpler surgery and a miniarthrotomy-approach are 
advantages of the technique. In patients with osteoarthrosis critical 
indication should take place. 
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Osteochondral lesions of the talus: a new one-step arthroscopic 
procedure for the regeneration of hyaline articular cartilage
S. Giannini1, R. Buda1, F. Vannini1, F. Di Caprio1, M. Cavallo1,
A. Gabriele2, B. Grigolo3;
1Orthopaedics Clinic, Rizzoli Orthopaedic Institute, University 
of Bologna, Bologna, Italy, 2Blood Bank And Muscolo-skeletal 
Bank, Rizzoli Orthopaedic Institute, University of, Bologna, Italy, 
3Immunology And Genetics Laboratory, Rizzoli Orthopaedic 
Institute, University of Bologna, Bologna, Italy
Purpose: Different methods have been proposed to date to achieve 
the regeneration of hyaline cartilage in osteochondral lesions of the 
talus (OLT). The aim of this study was to present a new one-step 
arthroscopic procedure with the use of mesenchimal stem cells 
(MSC) supported on a collagen scaffold and Platelet Rich Fibrin 
(PRF). 
Methods and Materials: 14 patients with a diagnosis of OLT 
underwent this procedure. The MSC were harvested from the 
posterior iliac crest and concentrated directly in the operating room. 
An ankle arthroscopy was performed with lesion detection and 
curettage. The cell concentrate was mixed with a collagen paste as 
scaffold and with PRF as a pool of growth factors in order to have 
B¾OBMDPNQPTJUFUP¾MMUIFMFTJPOTJUF1BSUJBMXFJHIUCFBSJOHGPS
months and early ROM was advised postoperatively. 
Results: According to the American Orthopaedic Foot and Ankle 
Score (AOFAS) system the patients had a preoperative score of 65.1 
(range 35-79), a postoperative of 69.4 (range 61-97) at 6 months 
and of 83.6 (range 65-100) at 12 months follow up. MRI control at 
6 and 12 months showed a progression of the reparative process in 
the osteochondral lesions. Histological and immunohystochemical 
analysis on a sample biopsed during a control arthroscopy at 12 
NPOUITDPO¾SNFEUIFIZBMJOFRVBMJUZPGUIFSFHFOFSBUFEDBSUJMBHF
Conclusions: This one-step technique demonstrated to be capable 
to regenerate hyaline cartilage, with the advantages of a reduced 
surgical time, lower costs and lower patient’s morbidity. 
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$BSUJMBHFSFHFOFSBUJPOXJUIDIPOESPDZUFTJO¾CSJOPHFOHFMTDBGGPME
and polylactate porous scaffold. An in vivo study in goats
A. Larsen1, C. Clausen2, K. Ostler2, H. Everland3, M. Lind4;
1Orthopedic, Aalborg Hospital, Aalborg, Denmark, 2Inc, Interface 
Biotech, Hoersholm, Denmark, 3Coloplast, Coloplast Research, 
humlebaek, Denmark, 4Orthopedics, Aarhus University Hospital, 
Sportstraumatology, Århus N, Denmark
Purpose: Recently porous scaffolds have been introduced for 
clinical cartilage tissue engineering. Numerous scaffold materials 
FYJTUBOE UIFPQUJNBMTDBGGPMEOFFET UPCF JEFOUJ¾FE5IFQSFTFOU
study aims to investigate the cartilage regenerative response of a 
QPMZMBDUBUF 	1-("
QPSPVT TDBGGPMEBOEB¾CSJO TDBGGPME DPNCJOFE
with chondrocyte suspension in a goat femoral condyle full thickness 
cartilage defect model. 
Methods and Materials: 20 adult goats were used for the study. 6 
mm circular defect was created in bilateral medial femoral condyles. 
Cartilage tissue was harvested for chondrocyte culture. At secondary 
open surgery the defects were randomized to the following four 
treatment groups .1. Empty defect (control) 2. Microfracture (control) 
3. Fibrin scaffold with chondrocytes and 4. Fibrin/chondrocyte 
solution in a PLGA porous scaffold. Animals were followed for 4 
month. Analyses: ICRS macroscopic scoring. Mechanical stiffness 
test of regeneration tissue. Histological analyses was performed 
CZ0%SJTDPMMBOE1JOBEBTDPSFTBOEQFSDFOUBHFUJTTVF¾MMJOHPGUIF
defects. 
Results: The cartilage regeneration is PLGA/Cell group demonstrated 
IJHIEFGFDU¾MMBOEBUJTTVFDIBSBDUFSJTUJDDMPTFUPIZBMJOFDBSUJMBHF
whereas no regeneration tissue was seen in the empty defects. 
5IF ¾CSJODIPOESPDZUF BOE NJDSPGSBDUVSF HSPVQ EFNPOTUSBUFE
limited repair tissue formation. Mechanical testing demonstrated no 
difference between treatment groups. 
Conclusions: The PLGA/cell construct demonstrates an extensive 
cartilage regenerative response with good phenotypic characteristic. 
Fibrin scaffold with chondrocytes and microfracture stimulated only 
limited cartilage repair tissue. A porous PLGA scaffold in combination 
with cultures chondrocytes seems to be a good technique for 
cartilage tissue engineering in vivo.
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&G¾DJFOUJOWJWPHFOFEFMJWFSZVTJOHDIJUPTBO%/"OBOPQBSUJDMFT
for applications in cartilage repair
S. Methot1, M. Lavertu2, J. Sun1, F. Smaoui3, M. Jean3, A. Merzouki3,
M.D. Buschmann4;
1Research And Development, Bio Syntech Canada Inc., Laval, 
Canada, 2Biomedical Engineering, Ecole Polytechnique de Montreal, 
Montreal, Canada, 3Immunology, INRS-Institut Armand-Frappier, 
Laval, Canada, 4Chemical Engineering And Biomedical Engineering, 
Ecole Polytechnique de Montreal, Montreal, Canada
Purpose: Chitosan is a cationic polymer that can condense plasmid 
DNA into nanosized gene vectors. We have recently published that 
TQFDJ¾DDIJUPTBOT	L%BBU%%"BOE%%"DBMMFEBOE
XIFSF%%"JTEFHSFFPGEFBDFUZMBUJPO
DBOFG¾DJFOUMZEFMJWFS
genes to cells in vitro. The purpose of this study was to examine in 
vivo gene delivery using these chitosan/DNA nanovectors. 
Methods and Materials: Chitosan/DNA nanoparticles were injected 
subcutaneously in mice, 5 times over a 7 week period using a pVax-
FGF2 plasmid. ELISA assays were used to quantify the expressed 
human proteins and anti-FGF2 antibodies in serum. Nanoparticles 
were used in a rabbit model where pVax-LacZ was injected 
TVCDVUBOFPVTMZXIJMF¿VPSFTDFOUOBOPQBSUJDMFTXFSFBQQMJFE UPB
chondral defect of the trochlea. 
Results: Using chitosan 92-10, FGF2 protein expression doubled 
compared to plasmid alone without detectable anti-FGF2 antibody. 
In contrast, anti-FGF2 antibodies were detected with chitosan 80-
10 without detectable protein suggesting the immune response 
to be sensitive to chitosan type. Subcutaneous injection of these 
nanoparticles in rabbits produced positive ȕ-Gal transfection in 
¾CSPCMBTUMJLFDFMMTXIJUFCMPPEDFMMTBOEBEJQPDZUFT'MVPSFTDFOUMZ
labeled chitosan/DNA nanoparticles were found to adhere and be 
resident in cartilage defects as revealed by confocal microscopy at 
TBDSJ¾DFIPVSTQPTUTVSHFSZ
Conclusions: Chitosan/DNA nanoparticles are promising therapeutic 
systems for repair and regeneration of joint tissues. Choice of a 
GPSNVMBUJPO XJUI IJHI USBOTGFDUJPO FG¾DJFODZ BOE MJNJUFE JNNVOF
response combined with the ability of chitosan to adhere to cartilage 
defects indicates a high potential to improve repair of cartilage and 
other joint tissues. 
